Padeliporfin Vascular Targeted Photodynamic Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has granted orphan drug designation to padeliporfin vascular targeted photodynamic therapy for use as a potential therapeutic option in patients with locally advanced pancreatic cancer.

United statesBarak palatchiEuropean unionImpact biotechPact biotechSolid tumorsPancreatic cancerPadeliporfin vtpOrphan drug designationPadeliporfin vascular targeted photodynamic therapy